133 related articles for article (PubMed ID: 27786597)
1. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
Moro C
Expert Opin Ther Targets; 2016 Dec; 20(12):1445-1452. PubMed ID: 27786597
[TBL] [Abstract][Full Text] [Related]
2. Defective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes.
Coué M; Badin PM; Vila IK; Laurens C; Louche K; Marquès MA; Bourlier V; Mouisel E; Tavernier G; Rustan AC; Galgani JE; Joanisse DR; Smith SR; Langin D; Moro C
Diabetes; 2015 Dec; 64(12):4033-45. PubMed ID: 26253614
[TBL] [Abstract][Full Text] [Related]
3. Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?
Pivovarova O; Gögebakan Ö; Klöting N; Sparwasser A; Weickert MO; Haddad I; Nikiforova VJ; Bergmann A; Kruse M; Seltmann AC; Blüher M; Pfeiffer AF; Rudovich N
J Clin Endocrinol Metab; 2012 May; 97(5):E731-9. PubMed ID: 22419733
[TBL] [Abstract][Full Text] [Related]
4. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
[TBL] [Abstract][Full Text] [Related]
5. Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men.
Verboven K; Hansen D; Moro C; Eijnde BO; Hoebers N; Knol J; Bouckaert W; Dams A; Blaak EE; Jocken JW
Clin Sci (Lond); 2016 Jul; 130(13):1105-14. PubMed ID: 27129190
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide system in the human retina.
Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
[TBL] [Abstract][Full Text] [Related]
7. Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor.
Jia B; Hasse A; Shi F; Collins S
PLoS One; 2023; 18(11):e0293636. PubMed ID: 37917630
[TBL] [Abstract][Full Text] [Related]
8. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
9. Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway.
Bordicchia M; Ceresiani M; Pavani M; Minardi D; Polito M; Wabitsch M; Cannone V; Burnett JC; Dessì-Fulgheri P; Sarzani R
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R104-14. PubMed ID: 27101299
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research.
Gruden G; Landi A; Bruno G
Diabetes Care; 2014 Nov; 37(11):2899-908. PubMed ID: 25342830
[TBL] [Abstract][Full Text] [Related]
11. Roles of guanylyl cyclase--a signaling in the cardiovascular system.
Saito Y; Kishimoto I; Nakao K
Can J Physiol Pharmacol; 2011 Aug; 89(8):551-6. PubMed ID: 21671770
[TBL] [Abstract][Full Text] [Related]
12. Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure.
Vassalle C; Andreassi MG; Prontera C; Fontana M; Zyw L; Passino C; Emdin M
Clin Chem; 2007 Nov; 53(11):1886-90. PubMed ID: 17890443
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes.
Kovacova Z; Tharp WG; Liu D; Wei W; Xie H; Collins S; Pratley RE
Obesity (Silver Spring); 2016 Apr; 24(4):820-8. PubMed ID: 26887289
[TBL] [Abstract][Full Text] [Related]
14. Impaired atrial natriuretic peptide-mediated lipolysis in obesity.
Rydén M; Bäckdahl J; Petrus P; Thorell A; Gao H; Coue M; Langin D; Moro C; Arner P
Int J Obes (Lond); 2016 Apr; 40(4):714-20. PubMed ID: 26499437
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies.
Takei Y; Inoue K; Trajanovska S; Donald JA
Gen Comp Endocrinol; 2011 May; 171(3):258-66. PubMed ID: 21362425
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes.
Coué M; Barquissau V; Morigny P; Louche K; Lefort C; Mairal A; Carpéné C; Viguerie N; Arner P; Langin D; Rydén M; Moro C
Sci Rep; 2018 Jan; 8(1):1097. PubMed ID: 29348496
[TBL] [Abstract][Full Text] [Related]
17. Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.
Schlueter N; de Sterke A; Willmes DM; Spranger J; Jordan J; Birkenfeld AL
Pharmacol Ther; 2014 Oct; 144(1):12-27. PubMed ID: 24780848
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of natriuretic peptide receptor specificity and degeneracy.
He XL; Dukkipati A; Garcia KC
J Mol Biol; 2006 Aug; 361(4):698-714. PubMed ID: 16870210
[TBL] [Abstract][Full Text] [Related]
19. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.
Pankow K; Wang Y; Gembardt F; Krause E; Sun X; Krause G; Schultheiss HP; Siems WE; Walther T
Circ Res; 2007 Oct; 101(9):875-82. PubMed ID: 17823376
[TBL] [Abstract][Full Text] [Related]
20. Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance.
Wu W; Shi F; Liu D; Ceddia RP; Gaffin R; Wei W; Fang H; Lewandowski ED; Collins S
Sci Signal; 2017 Jul; 10(489):. PubMed ID: 28743802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
